Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_04117
Species: Homo sapiens
Position : chr14:106152156-106153203
Year: 2024
Title: Core regions in immunoglobulin heavy chain enhancers essential for survival of non-Hodgkin lymphoma cells are identified by a CRISPR interference screen.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: Burkitt lymphoma (B-cell non-Hodgkin lymphoma)
PMID:  38934080
MONDO: MONDO:0007243
Tissue: blood
Tissue Ontology ID: UBERON:0000178
Cell Source: BL-41
Cell Type: B cell
Cell Ontology ID: CL:0000236
Experiment Type: IGH 3∩RR core peak 1; dense tiling CRISPRi-defined essential enhancer; eRNA-producing region; causal control of translocated MYC and lymphoma-cell survival
High Throughput Method: Tiling CRISPRi screen with NGS sgRNA quantification; chromatin-enriched RNA-seq
Low Throughput Method: Individual-sgRNA CRISPRi; GFP growth-competition assay; RT-qPCR for eRNA/MYC; BCR surface immunostaining/flow cytometry; MYC-rescue framework
About Target Gene
Target gene : MYC
About TF
TF name : NA
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19) 1 found
Enhancer ID Position Tissue Cell Disease
E_04118 chr14:106152156-106153203 blood B cell Burkitt lymphoma (B-cell non-Hodgkin lymphoma)
Expression of Target Genes for the Enhancer